Research and Markets has announced the addition of the "Gastro-Intestinal Stromal Tumors Pipeline Highlights - 2017" drug pipelines to their offering.

Gastro-Intestinal Stromal Tumors Pipeline Highlights - 2017 provides the most up-to-date information on key pipeline products in the global Gastro-Intestinal Stromal Tumors market. It covers emerging therapies for Gastro-Intestinal Stromal Tumors in active clinical development stages including early- and late-stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Gastro-Intestinal Stromal Tumors pipeline products by clinical trial stages, including both early- and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Gastro-Intestinal Stromal Tumors pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Gastro-Intestinal Stromal Tumors pipeline products by the company.

Short-term Launch Highlights:

Find out which Gastro-Intestinal Stromal Tumors pipeline products will be launched in the US and Ex-US till 2020.

Key Topics Covered:

1. Gastro-Intestinal Stromal Tumors Pipeline by Stages

2. Gastro-Intestinal Stromal Tumors Pipeline by Drug Class

3. Gastro-Intestinal Stromal Tumors Pipeline by Company

4. Gastro-Intestinal Stromal Tumors Phase 3 Clinical Trial Insights

5. Gastro-Intestinal Stromal Tumors Phase 2 Clinical Trial Insights

6. Gastro-Intestinal Stromal Tumors Phase 1 Clinical Trial Insights

7. Gastro-Intestinal Stromal Tumors Preclinical Research Insights

8. Gastro-Intestinal Stromal Tumors Discovery-Stage Insights

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/f89vs9/gastrointestinal.